Avanos Medical Inc (N:AVNS)

Business Focus: Medical Equipment, Supplies & Distribution

Feb 21, 2024 06:18 pm ET
Avanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products Recall
ALPHARETTA, Ga., Feb. 21, 2024 /PRNewswire/ -- In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024. These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of the feeding tube.
Feb 20, 2024 06:00 am ET
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 Results
ALPHARETTA, Ga., Feb. 20, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2023 results.
Feb 13, 2024 07:41 pm ET
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results
ALPHARETTA, Ga., Feb. 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2023 on Tuesday, Feb. 20 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
Feb 12, 2024 11:55 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / February 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 21, 2024 11:15 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 18, 2024 03:50 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
NEW YORK, NY / ACCESSWIRE / January 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 17, 2024 05:00 am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 16, 2024 06:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 15, 2024 05:00 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 12, 2024 07:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 11, 2024 07:00 am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 10, 2024 07:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 09, 2024 07:00 am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 08, 2024 03:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws.
Jan 04, 2024 07:00 am ET
Avanos Medical, Inc. Reports Preliminary Fourth Quarter and Full-Year 2023 Financial Results; Revises Preliminary 2024 Revenue Outlook
ALPHARETTA, Ga., Jan. 4, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for 2024.
Jan 02, 2024 09:53 am ET
Avanos Medical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, Jan. 8 at approximately 3:45 p.m., PST.
Nov 07, 2023 12:08 pm ET
Avanos Medical, Inc. to Present at the Stifel 2023 Healthcare Conference
ALPHARETTA, Ga., Nov. 7, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer, will participate in an analyst-led fireside chat at the Stifel 2023 Healthcare Conference on Tuesday, Nov. 14 at approximately 10:20 a.m. ET.
Nov 01, 2023 07:00 am ET
Avanos Medical, Inc. Announces Third Quarter 2023 Results
Strong Free Cash Flow Generation in Excess of $25 Million
Oct 25, 2023 09:30 am ET
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2023 Financial Results
ALPHARETTA, Ga., Oct. 25, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2023 on Wednesday, Nov. 1 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
Sep 12, 2023 06:37 am ET
Avanos Medical, Inc. to Present at the CL King Annual Best Ideas Conference
ALPHARETTA, Ga., Sept. 12, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 21st Annual Best Ideas Conference 2023 on Mon., Sept. 18 at approximately 8:45 a.m. Eastern Time.
Jun 28, 2023 04:11 pm ET
Jun 19, 2023 01:00 pm ET
Avanos Medical, Inc. Announces Agreement to Acquire Diros Technology Inc.
Unique tined-probe technology further differentiates Avanos portfolio
Jun 13, 2023 08:00 am ET
Avanos Medical, Inc. To Host Investor Day on June 20, 2023
ALPHARETTA, Ga., June 13, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it will host an Investor Day at Convene on 101 Park Avenue, New York, on Tuesday, June 20th, 2023.
Jun 08, 2023 06:50 am ET
Avanos Medical, Inc. Announces Sale of Respiratory Health Business to SunMed Group Holdings, LLC
ALPHARETTA, Ga., June 8, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to sell its Respiratory Health (RH) business to SunMed Group Holdings, LLC (SunMed).
May 03, 2023 07:00 am ET
Avanos Medical, Inc. Announces First Quarter 2023 Results
ALPHARETTA, Ga., May 3, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2023 financial results.
Apr 26, 2023 09:53 am ET
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2023 Financial Results
ALPHARETTA, Ga., April 26, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2023 on Wednesday, May 3 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
Mar 15, 2023 07:41 am ET
Avanos Medical, Inc. to Present at the 2023 Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
ALPHARETTA, Ga., March 15, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer and chief transformation officer, will present and participate in an analyst-led fireside chat at the 2023 virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wed., March 22 at approximately 9:45 a.m., ET.
Feb 21, 2023 06:00 am ET
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2022 Results
ALPHARETTA, Ga., Feb. 21, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2022 results.
Feb 14, 2023 04:49 am ET
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2022 Financial Results
ALPHARETTA, Ga., Feb. 14, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2022 on Tuesday, Feb. 21 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
Jan 11, 2023 06:15 am ET
Avanos Medical, Inc. Announces New Leadership Appointments
ALPHARETTA, Ga., Jan. 11, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced two executive leadership appointments that support the company's long-term strategic priorities: Michael Greiner has been named chief transformation officer (in addition to his current responsibilities as senior vice president and chief financial officer), and Kerr Holbrook has been named senior vice president and chief commercial officer.
Jan 04, 2023 01:36 pm ET
Avanos Medical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 4, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Wednesday, Jan. 11 at approximately 4:30 p.m., PST.
Nov 14, 2022 06:15 am ET
Avanos Medical, Inc. Appoints Sudhakar Varshney as Senior Vice President, Global Supply Chain & Procurement
ALPHARETTA, Ga., Nov. 14, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Sudhakar Varshney has been appointed senior vice president, global supply chain & procurement. In this role, Varshney will lead a multinational team of more than 2,500 employees to drive the development and execution of the Company's supply chain capabilities worldwide.
Nov 08, 2022 02:41 pm ET
Avanos Medical, Inc. to Present at the Stifel 2022 Healthcare Conference
ALPHARETTA, Ga., Nov. 8, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer, will present at the Stifel 2022 Healthcare Conference on Tuesday, Nov. 15 at approximately 3:35 p.m., ET.
Nov 02, 2022 07:00 am ET
Avanos Medical, Inc. Announces Third Quarter 2022 Results
ALPHARETTA, Ga., Nov. 2, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2022 financial results.
Oct 26, 2022 06:56 am ET
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2022 Financial Results
ALPHARETTA, Ga., Oct. 26, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2022 on Wednesday, Nov. 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
Sep 07, 2022 07:31 am ET
Avanos Medical, Inc. To Present at the Morgan Stanley 20th Annual Global Healthcare Conference
ALPHARETTA, Ga., Sept. 7, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer, will present and participate in an analyst-led fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 14 at approximately 1:30 p.m., ET.
Aug 09, 2022 07:00 am ET
Avanos Medical, Inc. Announces Second Quarter 2022 Results
ALPHARETTA, Ga., Aug. 9, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2022 financial results.
Jul 27, 2022 10:51 pm ET
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2022 Financial Results
ALPHARETTA, Ga., July 27, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2022 on Tuesday, August 9 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
May 17, 2022 10:54 am ET
Avanos Medical, Inc. to Present at the UBS 2022 Global Healthcare Conference
ALPHARETTA, Ga., May 17, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present and participate in a fireside chat at the UBS 2022 Global Healthcare Conference on Monday, May 23 at approximately 1:15 p.m., ET.
May 04, 2022 07:00 am ET
Avanos Medical, Inc. Announces First Quarter 2022 Results
ALPHARETTA, Ga., May 4, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2022 financial results.
Apr 27, 2022 01:38 pm ET
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2022 Financial Results
ALPHARETTA, Ga., April 27, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2021 on Wednesday, May 4 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
Mar 15, 2022 09:34 am ET
Avanos Medical, Inc. to Present at the Virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum
ALPHARETTA, Ga., March 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer, will present and participate in an analyst-led fireside chat at the virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum on Tues., March 22 at approximately 9:45 a.m., ET.
Feb 23, 2022 06:00 am ET
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2021 Results
ALPHARETTA, Ga., Feb. 23, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2021 results.
Feb 15, 2022 10:35 am ET
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results
ALPHARETTA, Ga., Feb. 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2021 on Wednesday, Feb. 23 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
Jan 10, 2022 08:07 am ET
Avanos Medical, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 10, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference via webcast on Tuesday, Jan. 11 at approximately 10:30 a.m., ET.
Dec 15, 2021 03:15 pm ET
Avanos Medical, Inc. Announces Share Repurchase Authorization
ALPHARETTA, Ga., Dec. 15, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that its Board of Directors has approved a share repurchase program authorizing Avanos to purchase up to $30 million of the company's common stock. The Company expects to fund repurchases under this program from the company's existing cash or future cash flow.
Dec 13, 2021 03:05 pm ET
Avanos Medical, Inc. Announces Agreement To Acquire OrthogenRx, Inc.
ALPHARETTA, Ga., Dec. 13, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire OrthogenRx, Inc., an emerging leader in viscosupplementation therapies for the treatment of knee osteoarthritis (OA) pain, for a total consideration of $160 million. The purchase price consists of $130 million in cash at closing plus an additional $30 million in contingent cash consideration, payable upon the achievement of growth milestones related to the company's commercial hyaluronic acid (HA) therapy products, GenVisc® 850 and TriVisc®.
Dec 02, 2021 09:00 am ET
Avanos Medical, Inc. Launches PainBlock Pro App
ALPHARETTA, Ga., Dec. 2, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its PainBlock Pro data collection and patient engagement app. The app/text message-based platform allows healthcare providers to track patients' recovery in real time for up to 10 days post-surgery.
Nov 02, 2021 07:00 am ET
Avanos Medical, Inc. Announces Third Quarter 2021 Results
ALPHARETTA, Ga., Nov. 2, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2021 financial results.
Oct 26, 2021 07:00 am ET
Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2021 Financial Results
ALPHARETTA, Ga., Oct. 26, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2021 on Tuesday, Nov. 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
Aug 03, 2021 07:00 am ET
Avanos Medical, Inc. Announces Second Quarter 2021 Results
ALPHARETTA, Ga., Aug. 3, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2021 financial results.
Aug 02, 2021 09:31 am ET
Thinking about trading options or stock in BioNTech, Nio, Moderna, Facebook, or Avanos Medical?
NEW YORK, Aug. 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNTX, NIO, MRNA, FB, and AVNS.
Jul 27, 2021 07:00 am ET
Avanos Medical, Inc. To Webcast Conference Call Discussing Second Quarter 2021 Financial Results
ALPHARETTA, Ga., July 27, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2021 on Tuesday, August 3 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Jul 12, 2021 07:15 am ET
Avanos Medical, Inc. Appoints Moji James as Senior Vice President & General Counsel
ALPHARETTA, Ga., July 12, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Moji James has been appointed senior vice president & general counsel. In this role, James will oversee the Company's legal, government relations and global security functions.
Jun 18, 2021 07:00 am ET
Avanos Medical, Inc. to Present at the 2021 Raymond James Human Health Innovation Conference
ALPHARETTA, Ga., June 18, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present and participate in an analyst-led fireside chat at the Virtual 2021 Raymond James Human Health Innovation Conference Tues., June 22 at approximately 10:40 a.m., ET.
Feb 24, 2021 06:00 am ET
Avanos Medical, Inc. to Present at the Virtual Raymond James 42nd Annual Institutional Investors Conference
ALPHARETTA, Ga., Feb. 24, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raymond James 42nd Annual Institutional Investors Conference Mon., March 1 at approximately 3:50 p.m., ET
Feb 18, 2021 06:00 am ET
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2020 Results
ALPHARETTA, Ga., Feb. 18, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2020 results.
Feb 11, 2021 06:00 am ET
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full-Year 2020 Financial Results
ALPHARETTA, Ga., Feb. 11, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full-year 2020 on Thursday, Feb. 18 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Jan 06, 2021 06:00 am ET
Avanos Medical, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 6, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 39th Annual J.P. Morgan Healthcare Conference via webcast on Wednesday Jan. 13 at approximately 2 p.m. ET.
Nov 05, 2020 06:00 am ET
Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in November
ALPHARETTA, Ga., Nov. 5, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in November:
Nov 03, 2020 06:00 am ET
Avanos Medical, Inc. Announces Third Quarter 2020 Results
ALPHARETTA, Ga., Nov. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2020 financial results.
Oct 27, 2020 07:00 am ET
Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2020 Financial Results
ALPHARETTA, Ga., Oct. 27, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2020 on Tuesday, Nov. 3 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Aug 04, 2020 07:00 am ET
Avanos Medical, Inc. Announces Second Quarter 2020 Results
ALPHARETTA, Ga., Aug. 4, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2020 financial results.
Jul 28, 2020 07:00 am ET
Avanos Medical, Inc. To Webcast Conference Call Discussing Second Quarter 2020 Financial Results
ALPHARETTA, Ga., July 28, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2020 on Tuesday, Aug. 4 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Jul 02, 2020 09:00 am ET
MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings
MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the closing of concurrent $150 million private equity and debt financings,...
May 28, 2020 07:00 am ET
Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in June
ALPHARETTA, Ga., May 28, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in June:
May 06, 2020 07:00 am ET
Avanos Medical, Inc. Announces First Quarter 2020 Results and Provides an Update on its Response to the COVID-19 Pandemic
ALPHARETTA, Ga., May 6, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2020 financial results and provided an update on the actions it's taking in response to the COVID-19 pandemic.
Apr 29, 2020 07:00 am ET
Avanos Medical, Inc. To Webcast Conference Call Discussing First Quarter 2020 Financial Results
ALPHARETTA, Ga., April 29, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2020 on Wednesday, May 6 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Apr 16, 2020 04:00 pm ET
Avanos Medical, Inc. Changes to Virtual Meeting Format for 2020 Annual Meeting of Stockholders
ALPHARETTA, Ga., April 16, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that, due to the increasing public health risk posed by COVID-19 and in accordance with current governmental state of emergency orders, its 2020 Annual Meeting of Stockholders will be changed from an in-person meeting to a virtual meeting to be held solely by means of remote communication.
Mar 18, 2020 03:48 pm ET
INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Avanos Medical, Inc. for Potential Breach of Fiduciary Duty Claims
Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Avanos Medical, Inc. (NYSE: AVNS). If you are a shareholder of Avanos Medical, Inc. and wish to receive additional...
Nov 13, 2019 06:00 am ET
Avanos Medical, Inc. to Present at the Stifel 2019 Healthcare Conference
ALPHARETTA, Ga., Nov. 13, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Stifel 2019 Healthcare Conference in New York City on Wednesday, Nov. 20 at approximately 8 a.m., ET.
Nov 06, 2019 06:00 am ET
Avanos Medical, Inc. Announces Participation in the Stephens Nashville Investment Conference
ALPHARETTA, Ga., Nov. 6, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Crawford, vice president of investor relations, will present at the Stephens Nashville Investment Conference at the Omni Nashville hotel in Nashville, TN on Wednesday, Nov. 13 at approximately 1:45 p.m., CT.
Nov 05, 2019 06:00 am ET
Avanos Medical, Inc. Announces Third Quarter 2019 Results, Completes Acquisition of Endoclear LLC
ALPHARETTA, Ga., Nov. 5, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2019 results and revised its full-year 2019 outlook.
Oct 29, 2019 08:00 am ET
Avanos Medical, Inc. Announces Webcast of Third Quarter 2019 Financial Results Conference Call
ALPHARETTA, Ga., Oct. 29, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2019 on Tuesday, Nov. 5 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Sep 26, 2019 04:19 pm ET
New Data Supports COOLIEF* Cooled Radiofrequency to be Effective in Relieving Chronic Knee Pain
ALPHARETTA, Ga., Sept. 26, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced publication acceptance from a large retrospective study demonstrating long-term clinical effectiveness of COOLIEF* Cooled Radiofrequency (RF) for patients suffering from chronic osteoarthritic knee pain in a diverse patient population.
Sep 17, 2019 08:07 am ET
BioQ Pharma Announces Partnership with Avanos Medical
SAN FRANCISCO, Sept. 17, 2019 /PRNewswire/ -- BioQ Pharma Incorporated, a specialty pharmaceutical company, today announced that it has entered into a Development, Supply, Distribution Agreement with Avanos Medical, Inc. (NYSE: AVNS, "Avanos"). Under the agreement, the parties will work together to obtain appropriate regulatory approvals and commercialize self-contained, infusible, non-opioid post-operative pain pharmaceutical product in the United States, Canada and Mexico. Avanos, which established the iconic On-Q brand, brings deep commercial expertise to enable the wide-scale launch of B
Aug 29, 2019 07:00 am ET
Avanos Medical, Inc. to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
ALPHARETTA, Ga., Aug. 29, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt hotel in New York on Monday, Sept. 9 at approximately 1:40 p.m., ET.
Aug 06, 2019 07:00 am ET
Avanos Medical, Inc. Announces Second Quarter 2019 Results, Completes Acquisition of NeoMed, Inc., Announces Agreement to Acquire Substantially All the Assets of Summit Medical Products, Inc., Announc
ALPHARETTA, Ga., Aug. 6, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2019 results and revised its full-year 2019 outlook.
Jul 23, 2019 07:00 am ET
Avanos Medical, Inc. Announces Webcast of Second Quarter 2019 Financial Results Conference Call
ALPHARETTA, Ga., July 23, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2019 on Tuesday, Aug. 6 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
May 28, 2019 07:00 am ET
Avanos Medical Receives Innovative Technology Designation from Vizient for CORTRAK*
ALPHARETTA, Ga., May 28, 2019 /PRNewswire/ -- Avanos Medical (NYSE: AVNS), a company focused on delivering clinically superior medical device solutions to improve patients' quality of life, announced today that its CORTRAK* Enteral Access System has received a 2019 Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the country.
May 09, 2019 07:00 am ET
Avanos Medical, Inc. Announces Tender Offer for Senior Notes
ALPHARETTA, Ga., May 9, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") announced today that it commenced a cash tender offer (the "Tender Offer") to purchase up to $129,840,000 in aggregate purchase price (the "Tender Cap") of its outstanding 6.250 percent Senior Unsecured Notes due October 15, 2022 (the "Notes").  Avanos is commencing the Tender Offer in order to satisfy its obligations under the terms of the indenture pursuant to which the Notes were issued (the "Indenture").  Pursuant to the Indenture, Avanos is required to make an offer to the holders of the Notes to p
May 07, 2019 07:00 am ET
Avanos Medical, Inc. Announces First Quarter 2019 Results
ALPHARETTA, Ga., May 7, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2019 results.
Apr 23, 2019 07:00 am ET
Avanos Medical, Inc. To Webcast Conference Call Discussing First Quarter 2019 Financial Results
ALPHARETTA, Ga., April 23, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2019 on Tuesday, May 7 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Apr 03, 2019 07:00 am ET
Avanos Medical Announces FDA Clearance for ON-Q* with Bolus
ALPHARETTA, Ga., April 3, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a company focused on delivering clinically superior medical device solutions to improve patients' quality of life, announced today that it has received U.S. Food and Drug Administration (FDA) 501(k) clearance for its ON-Q* with Bolus pump. The new ON-Q* with Bolus design incorporates improvements that make it simpler for providers and patients to use while reducing postoperative opioid use to achieve pain management.
Mar 06, 2019 06:00 am ET
Avanos Medical, Inc. to Present at the Barclays Global Healthcare Conference
ALPHARETTA, Ga., March 6, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Barclays Global Healthcare Conference on Wednesday, March 13 at approximately 9:30 a.m. ET at the Loews Miami Beach Hotel, Miami Beach, Florida.
Mar 04, 2019 06:00 am ET
COOLIEF* Cooled Radiofrequency Achieves Statistically Significant Reductions in Pain and Improved Function Compared to Hyaluronic Acid Injection
ALPHARETTA, Ga., March 4, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that its study comparing COOLIEF* Cooled Radiofrequency to hyaluronic acid (HA) in the management of knee pain achieved its primary endpoint with a statistically significant improvement in knee osteoarthritis patients experiencing at least 50 percent reduction in knee pain at 6 months after treatment (p < 0.0001). COOLIEF* patients also achieved a statistically greater improvement in their functional outcomes when compared to the HA group at this 6-month time point (p < 0.0001).  The full s
Feb 27, 2019 06:00 am ET
Avanos Medical, Inc. to Present at the Raymond James 40th Annual Institutional Investors Conference
ALPHARETTA, Ga., Feb. 27, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Steve Voskuil, chief financial officer, will present at the Raymond James 40th Annual Institutional Investors Conference on Wednesday, March 6 at approximately 11 a.m. ET at the JW Marriott Orlando Grande Lakes in Orlando, Florida.
Feb 26, 2019 06:00 am ET
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2018 Results, Provides 2019 Outlook
ALPHARETTA, Ga., Feb. 26, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2018 results.
Feb 12, 2019 06:00 am ET
Avanos Medical, Inc. To Webcast Conference Call Discussing Fourth Quarter and Full-Year 2018 Financial Results
ALPHARETTA, Ga., Feb. 12, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full-year 2018 and its 2019 outlook on Tuesday, Feb. 26 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Jan 03, 2019 06:00 am ET
Avanos Medical, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 3, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday Jan. 10 at approximately 8:30 a.m. PT at the Westin St. Francis Hotel in San Francisco. Following the presentation Woody and Steve Voskuil, senior vice president and chief financial officer, will answer questions about the company.
Dec 17, 2018 06:00 am ET
Avanos Medical, Inc. Appoints David Ball as Senior Vice President, Global Supply Chain & Procurement
ALPHARETTA, Ga., Dec. 17, 2018 /PRNewswire/ -- Avanos Medical, Inc. today announced that David Ball has been appointed senior vice president, global supply chain & procurement. In this role, Ball will spearhead an integrated supply chain strategy to support Avanos' continued growth and transformation. Previously, Ball served as senior vice president of operations at Acelity where he led the company's global manufacturing operations and oversaw its inventory, supply chain, procurement and facilities functions.
Dec 10, 2018 06:00 am ET
Avanos Among Winners of FDA's Opioid Innovation Challenge
ALPHARETTA, Ga., Dec. 10, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) is pleased to announce it has been selected as one of eight winners of the FDA's Opioid Addiction Innovation Challenge. The product selected is an enhanced nerve visualization system in development by Avanos' Acute Pain division.  
Nov 16, 2018 09:00 am ET
Avanos Medical Presents New Preclinical Data Comparing the Outcomes of COOLIEF* Cooled Radiofrequency to Standard RF
ALPHARETTA, Ga., Nov. 16, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) presented new scientific research supporting the long-term effects seen in COOLIEF* Cooled Radiofrequency (RF) for the management of chronic pain at the 17th Annual American Society of Regional Anesthesia and Pain Medicine (ASRA) meeting.
Nov 06, 2018 06:00 am ET
Avanos Medical, Inc. Announces Third Quarter 2018 Results, Affirms Full-Year Adjusted Diluted Earnings Per Share Guidance
ALPHARETTA, Ga., Nov. 6, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2018 results and affirmed its full-year 2018 adjusted diluted earnings per share outlook of $1.75 to $1.90.
Nov 05, 2018 06:00 am ET
Avanos Medical, Inc. to Present at Stifel 2018 Healthcare Conference
ALPHARETTA, Ga., Nov. 5, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Stifel 2018 Healthcare Conference at The Lotte New York Palace Hotel in New York City on Tuesday, Nov. 13 at approximately 11 a.m., ET.
Oct 23, 2018 07:00 am ET
Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2018 Financial Results
ALPHARETTA, Ga., Oct. 23, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2018 on Tuesday, Nov. 6 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Sep 06, 2018 07:00 am ET
Avanos Medical, Inc. to Present at Morgan Stanley Global Healthcare Conference
ALPHARETTA, Ga., Sept. 6, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Steve Voskuil, chief financial officer, will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt hotel in New York on Thursday, Sept. 13 at approximately 10:35 a.m., ET.
Aug 07, 2018 07:00 am ET
Avanos Medical, Inc. Announces Second Quarter 2018 Results, Raises Full-Year 2018 Outlook
ALPHARETTA, Ga., Aug. 7, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2018 results, raised its full-year 2018 Medical Device net sales expectations and adjusted diluted earnings per share outlook.
Jul 24, 2018 07:00 am ET
Avanos Medical, Inc. To Webcast Conference Call Discussing Second Quarter 2018 Financial Results
ALPHARETTA, Ga., July 24, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2018 on Tuesday, Aug. 7 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
Jul 16, 2018 07:00 am ET
Leiters and Avanos Medical Announce Preferred Provider Agreement
DENVER, July 16, 2018 /PRNewswire/ -- Leiters, an FDA-registered 503B outsourcing provider of high quality ophthalmology and hospital-based services, and Avanos Medical Inc. (NYSE:AVNS), a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life, announced today a preferred provider relationship to fill the ON-Q* Pain Relief System. In the midst of the national drug shortage, many of Avanos' acute and non-acute customers have requested assistance with filling the ON-Q* Pain Relief System. Leiters will serv
Jul 02, 2018 04:01 pm ET
Avanos Medical Closes Acquisition of CoolSystems, Inc., Marketed as Game Ready®
ALPHARETTA, Ga., July 2, 2018 /PRNewswire/ -- Avanos Medical Inc. (NYSE: AVNS) ("Avanos" or "The Company") announced today the completion of its acquisition of CoolSystems, Inc., marketed as Game Ready ("Game Ready"), a market-leading provider of cold therapy and compression therapy systems, for a total consideration of $65 million in cash.
Jun 21, 2018 04:01 pm ET
Halyard Health Hosts Inaugural Analyst and Investor Meeting
ALPHARETTA, Ga., June 21, 2018 /PRNewswire/ -- Halyard Health, Inc. (NYSE: HYH) ("Halyard", or "the Company", or "Avanos") today hosted its inaugural analyst and investor meeting in New York, where it presented the company's new strategic framework and its plan for delivering the next chapter of growth alongside an update around the company's rebranding and renaming into "Avanos". Avanos' leadership team provided additional detail on its strategy to accelerate growth and performance across the organization; updates on its two core franchises, Pain Management and Chronic Care; and, an overvie
Jun 01, 2018 08:30 am ET
Halyard Health Announces Corporate Rebranding, Changes Name to Avanos Medical, Inc.
ALPHARETTA, Ga., June 1, 2018 /PRNewswire/ -- Halyard Health, Inc. (NYSE: HYH) a market-leading medical devices company, today announced the business' rebrand to Avanos Medical, Inc. ("Avanos"). Avanos' vision is to be the best at getting patients back to the things that matter. Derived from the words "advanced" and "innovation," the new name and brand emphasize the company's focus on innovating with speed to deliver better, more sustainable patient outcomes.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.